{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:43:57Z","timestamp":1784371437002,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T00:00:00Z","timestamp":1541116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["18-015-00009"],"award-info":[{"award-number":["18-015-00009"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.biopha.2018.09.182","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T07:00:49Z","timestamp":1542178849000},"page":"1556-1562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Galanin\/GalR1-3 system: A promising therapeutic target for myocardial ischemia\/reperfusion injury"],"prefix":"10.1016","volume":"109","author":[{"given":"Marina","family":"Palkeeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-3817","authenticated-orcid":false,"given":"Irina","family":"Studneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Molokoedov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Serebryakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Veselova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ovchinnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sidorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Pisarenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.09.182_bib0005","first-page":"146","article-title":"Galanin receptors and ligands","volume":"3","author":"Webling","year":"2012","journal-title":"Froint. Endocrinol."},{"issue":"12","key":"10.1016\/j.biopha.2018.09.182_bib0010","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00018-008-8153-8","article-title":"Galanin, galanin receptors and drug targets","volume":"65","author":"Mitsukawa","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2018.09.182_bib0015","first-page":"113","article-title":"Neurochemical modulation of central cardiovascular control: the integrative role of galanin","volume":"102","author":"D\u00edaz-Cabiale","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.biopha.2018.09.182_bib0020","doi-asserted-by":"crossref","first-page":"31949","DOI":"10.1074\/jbc.272.51.31949","article-title":"Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes","volume":"272","author":"Wang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.09.182_bib0025","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.2042-7158.1998.tb03360.x","article-title":"The influence of the neuropeptide galanin on the contractility and the effective refractory period of guinea-pig heart papillary muscle under normoxic and hypoxic conditions","volume":"50","author":"Kocic","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2018.09.182_bib0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF00374301","article-title":"Galanin activates an inwardly rectifying potassium conductance in mudpuppy atrial myocytes","volume":"422","author":"Parsons","year":"1993","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.biopha.2018.09.182_bib0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2008.03.012","article-title":"Post-infarct cardiac sympathetic hyperactivity regulates galanin expression","volume":"436","author":"Ewert","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2018.09.182_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.npep.2010.10.002","article-title":"Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms","volume":"45","author":"Alston","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2018.09.182_bib0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1523\/JNEUROSCI.23-02-00416.2003","article-title":"The second galanin receptor GalR2 plays a key role in neurite outgrowth from adult sensory neurons","volume":"23","author":"Mahoney","year":"2003","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.biopha.2018.09.182_bib0050","doi-asserted-by":"crossref","first-page":"21241","DOI":"10.18632\/oncotarget.15071","article-title":"Myocardial protection from ischemia\/reperfusion injury by exogenous galanin fragment","volume":"8","author":"Timotin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2018.09.182_bib0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.npep.2004.12.009","article-title":"Role of galanin and galanin(1\u201315) on central cardiovascular control","volume":"39","author":"D\u0131\u0491az-Cabiale","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2018.09.182_bib0060","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/mnfr.200900317","article-title":"Diet-induced obesity regulates the galanin-mediated signaling cascade in the adipose tissue of mice","volume":"54","author":"Kim","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.biopha.2018.09.182_bib0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.physbeh.2011.02.023","article-title":"Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats","volume":"103","author":"He","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2018.09.182_bib0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-6147(00)01446-2","article-title":"Galanin receptor subtypes","volume":"21","author":"Branchek","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2018.09.182_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.npep.2016.08.008","article-title":"Ala5-galanin (2\u201311) is a Gal2R specific galanin analogue","volume":"60","author":"Webling","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2018.09.182_bib0080","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.161293598","article-title":"Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors","volume":"98","author":"Liu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.09.182_bib0085","doi-asserted-by":"crossref","first-page":"31949","DOI":"10.1074\/jbc.272.51.31949","article-title":"Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes","volume":"272","author":"Wang","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"60","key":"10.1016\/j.biopha.2018.09.182_bib0090","doi-asserted-by":"crossref","first-page":"101659","DOI":"10.18632\/oncotarget.21503","article-title":"Cardioprotective properties of N-terminal galanin fragment (2-15) in experimental ischemia\/reperfusion injury","volume":"8","author":"Pisarenko","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.biopha.2018.09.182_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/phrs.1996.0099","article-title":"Galanin, galantide and galanin (1-14)-[\u03b1-aminobutyric acid8]-scyliorhinin-I: structure dependent effects on the rat isolated gastric fundus","volume":"35","author":"Korolkiewicz","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2018.09.182_bib0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.npep.2009.04.004","article-title":"A novel GalR2-specific peptide agonist","volume":"43","author":"Runesson","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2018.09.182_bib0105","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0040-4039(00)99616-3","article-title":"New coupling reagents in peptide chemistry","volume":"30","author":"Knorr","year":"1989","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.biopha.2018.09.182_bib0110","series-title":"The State Pharmacopoeia of the Russian Federation XIII Edition","year":"2015"},{"issue":"1\/2","key":"10.1016\/j.biopha.2018.09.182_bib0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2018.09.182_bib0120","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.npep.2004.12.029","article-title":"Important pharmacophores for binding to galanin receptor 2","volume":"39","author":"Lundstr\u00f6m","year":"2005","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopha.2018.09.182_bib0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1432-1033.1994.tb18899.x","article-title":"Comparison of the solution structures of the chimeric peptides galanin (1-12)-Ala-neuropeptide Y (25-36) amide and galanin (1-12)-Pro- neuropeptide Y (25-36) amide","volume":"222","author":"Arvidsson","year":"1994","journal-title":"Eur. J. Biochem."},{"issue":"1\u20134","key":"10.1016\/j.biopha.2018.09.182_bib0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/biof.5520240109","article-title":"Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives","volume":"24","author":"Aldini","year":"2005","journal-title":"Biofactors"},{"key":"10.1016\/j.biopha.2018.09.182_bib0135","unstructured":"W.C. Chan, P.D. White, Fmoc Solid Phase Peptide Synthesis. Practical Approach 2004, 65\u201367."},{"issue":"6","key":"10.1016\/j.biopha.2018.09.182_bib0140","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/bip.21316","article-title":"Intrinsic amino acid side-chain hydrophilicity\/hydrophobicity coefficients determined by reversed-phase high-performance liquid chromatography of model peptides: comparison with other hydrophilicity\/hydrophobicity scales","volume":"92","author":"Mant","year":"2009","journal-title":"Biopolymers"},{"issue":"2","key":"10.1016\/j.biopha.2018.09.182_bib0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2007.05.009","article-title":"The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease","volume":"115","author":"Lang","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2018.09.182_bib0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1755-5922.12144","article-title":"Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure","volume":"33","author":"Chen","year":"2015","journal-title":"Cardiovasc. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2018.09.182_bib0155","article-title":"Protective effects of N-terminal galanin fragments in myocardial ischaemia\/reperfusion injury","volume":"38","author":"Gataulin","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2018.09.182_bib0160","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1471-4159.2007.04959.x","article-title":"Molecular characterization of the ligand binding site of the human galanin receptor type 2, identifying subtype selective interactions","volume":"103","author":"Lundstrom","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2018.09.182_bib0165","doi-asserted-by":"crossref","first-page":"31949","DOI":"10.1074\/jbc.272.51.31949","article-title":"Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes","volume":"272","author":"Wang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.09.182_bib0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bcp.2015.08.085","article-title":"New paradigms in GPCR drug discovery","volume":"98","author":"Jacobson","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2018.09.182_bib0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11010-014-2008-4","article-title":"Apelin-12 and its structural analog enhance antioxidant defense in experimental myocardial ischemia and reperfusion","volume":"391","author":"Pisarenko","year":"2014","journal-title":"Mol. Cell. Biochem."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218335637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218335637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:55:38Z","timestamp":1777877738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218335637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"alternative-id":["S0753332218335637"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.182","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galanin\/GalR1-3 system: A promising therapeutic target for myocardial ischemia\/reperfusion injury","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.09.182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}